Drogas anorexígenas en el tratamiento de la obesidad / Anorexigenic drugs in the treatment of obesity
Rev. méd. Chile
;
123(5): 637-40, mayo 1995.
Article
in Spanish
| LILACS
| ID: lil-152868
RESUMO
Obesity is highly prevalent and has several adverse effects on health. Its treatment is thus warranted and must aim to modify dietary and physical activity habits. The opinion of this association is that anorexigenic drugs with cathecolaminergic action (diethylpropion, phentermine, mazindol and phenylpropanolamine) or serotoninergic action (fenfluoramine and fluoxetine) may be used in moderate or severe obesity (BMI >30 kg/m2) after a complete clinical assessment and in the context of an integral medical treatment. This association recommends a close surveillance of the use of these drugs, specially when formulated as non-propietary prescriptions
Search on Google
Index:
LILACS (Americas)
Main subject:
Appetite Depressants
/
Obesity
Limits:
Humans
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
1995
Type:
Article
Similar
MEDLINE
...
LILACS
LIS